Standardization of insulin immunoassays: Report of the American Diabetes Association Workgroup

Clinical Chemistry

Volumn 53, Issue 4, 2007, Pages 711-716

  Marcovina, Santica ^a   Bowsher, Ronald R ^b,c   Miller, W Greg ^d   Staten, Myrlene ^e   Myers, Gary ^f   Caudill, Samuel P ^f   Campbell, Scott E ^g   Steffes, Michael W ^h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LINCO Diagnostic Services   (United States)

^c B2S Consulting   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^g AMERICAN DIABETES ASSOCIATION   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROINSULIN;

ACCURACY; ARTICLE; CROSS REACTION; HUMAN; IMMUNOASSAY; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MEDICAL SOCIETY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; UNITED STATES;

CROSS REACTIONS; DIABETES MELLITUS; HUMANS; IMMUNOASSAY; INSULIN; PROINSULIN;

EID: 34147195898     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.082214     Document Type: Article

References (8)

1. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, et al. Report of the American Diabetes Association's task force on standardization of the Insulin assay. Diabetes 1996;45:242-5.
2. Volund A, Brange J, Drejer K, Jensen I, Markussen J, Ribel U, et al. In vitro and in vivo potency of insulin analogues designed for clinical use. Diabet Med 1991;8:839-47.
3. Fraser CE. Biological Variation: From Principles to Practice. Washington, DC: AACC Press, 2001.
4. Haffner SM, Mykkanen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A, et al. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 1994;79:1806-10.
5. Given BD, Cohen RM, Shoelson SE, Frank BH, Rubenstein AH, Tager HS. Biochemical and clinical implications of proinsulin conversion intermediates. J Clin Invest 1985;76:1398-405.
6. Bowsher RR, Wolny JD, Frank BH. A rapid and sensitive RIA for the measurement of proinsulin in human serum. Diabetes 1992;41:1084-90.
7. Ostrega D, Polonsky K, Nagi D, Yudkin J, Cox LJ, Clark PMS, et al. Measurement of proinsulin and intermediates: Validation of immunoassay methods by HPLC. Diabetes 1995;44:437-40.
8. Cabaleiro DR, Stockl D, Kaufman JM, Fiers T, Thienpont LM. Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2006;52:1193-6.